Top Buy
Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Amgen Inc. | 26 | 0 | 1 | 0 | €292.90 | €298.90 | 2.047% |
Pfizer Inc. | 30 | 4 | 3 | 0 | €26.06 | €40.66 | 56.023% |
AbbVie Inc. | 30 | 0 | 9 | 0 | €160.82 | €175.39 | 9.062% |
Intra-Cellular Therapies Inc. | 30 | 0 | 5 | 0 | €71.50 | €83.49 | 16.773% |
Merck & Co. Inc. | 32 | 1 | 4 | 0 | €123.20 | €125.34 | 1.735% |
Insmed Inc. | 33 | 0 | 15 | 0 | €62.50 | €65.83 | 5.327% |
Neurocrine Bioscience | 33 | 0 | 4 | 0 | €126.20 | €140.87 | 11.622% |
Cytokinetics Inc. | 34 | 1 | 4 | 0 | €48.40 | €83.21 | 71.911% |
Alnylam Pharmace. | 36 | 0 | 0 | 0 | €213.20 | €244.43 | 14.649% |
Johnson & Johnson | 38 | 1 | 6 | 0 | €139.24 | €187.15 | 34.410% |
Regeneron Pharmaceuticals Inc. | 41 | 1 | 5 | 0 | €985.40 | €1,025.4 | 4.055% |
Biogen Inc. | 50 | 1 | 2 | 0 | €211.80 | €293.22 | 38.444% |
Vertex Pharmaceuticals Inc. | 50 | 2 | 5 | 0 | €437.60 | €429.29 | -1.899% |
Eli Lilly Corp. | 58 | 0 | 10 | 0 | €834.00 | €813.11 | -2.505% |